BS
Burugupalli Srinivas
About Burugupalli Srinivas
Data last updated:
Burugupalli Srinivas is a Director at Andhra Medi Pharma India Private Limited (since 2010), Director at Biofern Life Sciences Private Limited (since 2019) and Director at Quantlytix Private Limited (since 2024), and holds 2 more current directorships. The companies operate in Chemicals and Materials, Pharma and Information Technology. The 4 current companies with reported revenue have a combined latest revenue of ₹92.31 Cr; the largest is Andhra Medi Pharma India Private Limited at ₹76.02 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Andhra Medi Pharma India Private Limited U24233AP2009PTC065969 | Director | 03 Dec 2010 | 2009 | ₹76.02 Cr (FY 2025) | Active |
 Biofern Life Sciences Private Limited U24100KA2019PTC120330 | Director | 11 Jan 2019 | 2019 | ₹15.40 Cr (FY 2025) | Active |
 Quantlytix Private Limited U73100AP2012PTC080528 | Director | 29 Nov 2024 | 2012 | ₹87.8 Lakh (FY 2025) | Active |
| Andhra Mariscos Enterprises Private Limited U74999AP2017PTC107302 | Director | 20 Dec 2017 | 2017 | ₹1.2 Lakh (FY 2025) | Active |
| Balaji Aqua And Poultry Feed Llp AAC-8024 | Designated Partner | 10 Oct 2014 | 2014 | Active |
Board colleagues of Burugupalli Srinivas
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anjana Chilakapati | 01924734 | Andhra Medi Pharma India Private Limited | Director |
| Garikipati Kishore Kumar | 03305008 | Andhra Medi Pharma India Private Limited , Biofern Life Sciences Private Limited | Director |
| Kolathur Srinarayanan | 03306787 | Andhra Medi Pharma India Private Limited , Biofern Life Sciences Private Limited and 1 more | Director |
| Rajeev Chilakapati | 01924690 | Andhra Medi Pharma India Private Limited | Director |
| Sirigina Srinivasa Rao | 03434218 | Andhra Medi Pharma India Private Limited | Director |
| Mh Shyama Prasad | Biofern Life Sciences Private Limited | Company Secretary | |
| Yalamarthi Ramesh | 10101677 | Quantlytix Private Limited | Additional Director |
| Golla Sai Rupa | 10855888 | Quantlytix Private Limited | Director |
| Pathuri Surya Teja | 06473024 | Quantlytix Private Limited | Additional Director |
| Kotari Srinivasa Rao | 06969142 | Andhra Mariscos Enterprises Private Limited , Balaji Aqua And Poultry Feed Llp | Director |
| Satyanarayana Burugupalli | 08020342 | Andhra Mariscos Enterprises Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Burugupalli Srinivas
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Burugupalli Srinivas
Burugupalli Srinivas currently holds 5 directorships: Andhra Medi Pharma India Private Limited (Director, since 03 Dec 2010, revenue ₹76.02 Cr (FY 2025)); Biofern Life Sciences Private Limited (Director, since 11 Jan 2019, revenue ₹15.40 Cr (FY 2025)); Quantlytix Private Limited (Director, since 29 Nov 2024, revenue ₹87.8 Lakh (FY 2025)); Andhra Mariscos Enterprises Private Limited (Director, since 20 Dec 2017, revenue ₹1.2 Lakh (FY 2025)); Balaji Aqua And Poultry Feed Llp (Designated Partner, since 10 Oct 2014).
Burugupalli Srinivas was first appointed on 03 Dec 2010 as Director at Andhra Medi Pharma India Private Limited. The most recent appointment on record is 29 Nov 2024 at Quantlytix Private Limited.
The 4 current companies of Burugupalli Srinivas that report revenue have a combined latest revenue of ₹92.31 Cr: Andhra Medi Pharma India Private Limited ₹76.02 Cr (FY 2025); Biofern Life Sciences Private Limited ₹15.40 Cr (FY 2025); Quantlytix Private Limited ₹87.8 Lakh (FY 2025); Andhra Mariscos Enterprises Private Limited ₹1.2 Lakh (FY 2025).
The current boards of Burugupalli Srinivas's companies include Anjana Chilakapati (Andhra Medi Pharma India Private Limited), Garikipati Kishore Kumar (Andhra Medi Pharma India Private Limited), Kolathur Srinarayanan (Andhra Medi Pharma India Private Limited), Rajeev Chilakapati (Andhra Medi Pharma India Private Limited), Sirigina Srinivasa Rao (Andhra Medi Pharma India Private Limited), Mh Shyama Prasad (Biofern Life Sciences Private Limited), among others.